Showing 1 - 20 results of 31 for search '(( significant deaths decreased ) OR ( significantly ((greater decrease) OR (mean decrease)) ))~', query time: 0.52s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    S1 Data - by Marc S. Penn (16624541)

    Published 2023
    “…After adjusting for age, sex, and cardiovascular risk factors, risk of cardiovascular death did not differ significantly between patients with high and low MPO (HR, 1.57; 95% CI, 0.56–4.39), but patients with high MPO had greater risk of non-cardiovascular (HR, 6.15; 95% CI, 2.27–16.64) and all-cause (HR, 3.83; 95% CI, 1.88–7.78) death. …”
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    Factors associated with unfavorable treatment outcomes in people with RR or MDR TB (Gap 4). by Tulip A. Jhaveri (18625800)

    Published 2024
    “…<p>All studies used multivariable regression and reported adjusted effect estimates [<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref128" target="_blank">128</a>–<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref137" target="_blank">137</a>,<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref139" target="_blank">139</a>,<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref140" target="_blank">140</a>]. Estimates greater than 1 represent increased risk of unfavorable outcomes; estimates less than 1 represent decreased risk of unfavorable outcomes. …”
  18. 18

    Socioeconomic, psychosocial, and family- or society-related factors associated unfavorable treatment outcomes in people with drug-susceptible TB (Gap 4). by Tulip A. Jhaveri (18625800)

    Published 2024
    “…<p>All studies used multivariable regression and reported adjusted effect estimates [<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref066" target="_blank">66</a>,<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref067" target="_blank">67</a>,<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref071" target="_blank">71</a>–<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref073" target="_blank">73</a>,<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref077" target="_blank">77</a>,<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref081" target="_blank">81</a>,<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref084" target="_blank">84</a>,<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref086" target="_blank">86</a>,<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref087" target="_blank">87</a>,<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref089" target="_blank">89</a>–<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref094" target="_blank">94</a>,<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref099" target="_blank">99</a>–<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref105" target="_blank">105</a>,<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref108" target="_blank">108</a>–<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref110" target="_blank">110</a>,<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref123" target="_blank">123</a>]. Estimates greater than 1 represent increased risk of unfavorable outcomes; estimates less than 1 represent decreased risk of unfavorable outcomes. …”
  19. 19

    Supplementary Material for: A Retrospective Cohort Study on Patients with Lentigo Maligna Melanoma by Fröhlich S.M. (6717071)

    Published 2019
    “…The metastatic potential turned out to be low, entailing 7 deaths in the context of the LMM. <b><i>Conclusion:</i></b> Male gender, age over 70 at diagnosis, and a Breslow thickness greater than 0.75 mm were associated with a statistically significant decrease in overall disease-free survival in the current study. …”
  20. 20

    The first hundred days of COVID-19 in Pernambuco State, Brazil: epidemiology in historical context by Wayner Vieira de Souza (10354876)

    Published 2021
    “…We initially detected the spread of cases from the city center to the periphery of the state capital and Metropolitan Area, followed by rapid spread to the state’s interior. There was a decrease in the mean daily growth starting in April, but with an average threshold of more than 6,000 weekly cases of COVID-19. …”